Find clinical trials for Alzheimer's Disease in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Montréal, QC, CAN:
The study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT...
Phase 2
Greenfield Park, Quebec, Canada and 19 other locations
administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...
Phase 2
Greenfield Park, Quebec, Canada and 72 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Greenfield Park, Quebec, Canada and 246 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Greenfield Park, Quebec, Canada and 111 other locations
The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (inclu...
Phase 2
Greenfield Park, Quebec, Canada and 96 other locations
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...
Phase 3
Montreal, Quebec, Canada and 178 other locations
The purpose of this study is to:* Evaluate the safety and tolerability of intrathecal (IT) ALN-5288 in patients with Alzheimer's Disease...
Phase 1
Montreal, Quebec, Canada and 12 other locations
study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...
Phase 2
Montreal, Quebec, Canada and 200 other locations
This study is to be conducted in participants with early Alzheimer's Disease to test VY7523, a new drug being researched for treatm ...
Phase 1, Phase 2
Montreal, Quebec, Canada and 28 other locations
In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...
Phase 2
Montréal, Quebec, Canada and 137 other locations
Clinical trials
Research sites
Resources
Legal